# Ernexa Therapeutics Inc.: Form SC 13D/A, filed Sep 7, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D/A
- Filed: 2023-09-07
- Accepted by EDGAR: Sep 7, 2023, 17:26 ET
- Period: not reported
- Accession: 0001104659-23-099002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000110465923099002/tm2323568d4_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000110465923099002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000110465923099002/tm2323568d4_sc13da.htm

Filed Sep 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-099002. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.